Three-dimensional
(3D)
printing
is
an
emerging
fabrication
technology
that
allows
users
greater
control
over
their
medicinal
products.
In
particular,
selective
laser
sintering
(SLS),
a
subset
of
powder-based
fusion,
offers
high
resolution,
solvent-free,
minimal
and
simple
pre-formulation
steps.
However,
as
new
technology,
limited
number
formulations
have
been
explored
thus
far.
Realising
the
full
potential
SLS
will
require
large
to
be
investigated,
however,
this
invariably
result
in
costly
time-consuming
endeavour.
To
address
this,
study
introduces
inventive
machine
learning
(ML)
strategy,
Active
ML,
sustainably
accelerate
developments.
ML
operates
by
selectively
identifying
most
critical
test
from
overall
unknown
space,
enhancing
its
efficiency.
Among
1618
potentially
SLS-printable
thermoplastic
amassed
scientific
literature
internal
databases
were
untested,
two
feature
sets
employed
represent
them:
Material
Name
Physical
Properties.
working
through
five
human-machine
interactions,
selected
only
73
vast
pool
test.
A
subsequent
validation
using
set
accurately
predicted
six
out
eight
formulations'
printability,
demonstrating
extended
formulation
database
1800
whilst
testing
less
than
5%
formulations.
This
exemplifies
ML's
rapidly
increase
3D
space
significantly
decreasing
trials.
The
advantage
limitations
implementation
are
discussed.
Given
these
results,
proposed
methodology
poised
for
widespread
application
emergent
technologies,
expediting
development.
Advanced Materials,
Год журнала:
2023,
Номер
36(11)
Опубликована: Ноя. 10, 2023
Inkjet
printing
(IJP)
is
an
additive
manufacturing
process
that
selectively
deposits
ink
materials,
layer-by-layer,
to
create
3D
objects
or
2D
patterns
with
precise
control
over
their
structure
and
composition.
This
technology
has
emerged
as
attractive
versatile
approach
address
the
ever-evolving
demands
of
personalized
medicine
in
healthcare
industry.
Although
originally
developed
for
nonhealthcare
applications,
IJP
harnesses
potential
pharma-inks,
which
are
meticulously
formulated
inks
containing
drugs
pharmaceutical
excipients.
Delving
into
formulation
components
key
adaptable
material
deposition
enabled
by
unraveled.
The
review
extends
its
focus
substrate
including
paper,
films,
foams,
lenses,
3D-printed
showcasing
diverse
advantages,
while
exploring
a
wide
spectrum
therapeutic
applications.
Additionally,
benefits
hardware
software
improvements,
along
artificial
intelligence
integration,
discussed
enhance
IJP's
precision
efficiency.
Embracing
these
advancements,
holds
immense
reshape
traditional
processes,
ushering
era
medical
precision.
However,
further
exploration
optimization
needed
fully
utilize
capabilities.
As
researchers
push
boundaries
IJP,
vision
patient-specific
treatment
on
horizon
becoming
tangible
reality.
Pharmaceutics,
Год журнала:
2023,
Номер
15(5), С. 1448 - 1448
Опубликована: Май 10, 2023
3D
printing
technology
in
medicine
is
gaining
great
attention
from
researchers
since
the
FDA
approved
first
3D-printed
tablet
(Spritam®)
on
market.
This
technique
permits
fabrication
of
various
types
dosage
forms
with
different
geometries
and
designs.
Its
feasibility
design
pharmaceutical
very
promising
for
making
quick
prototypes
because
it
flexible
does
not
require
expensive
equipment
or
molds.
However,
development
multi-functional
drug
delivery
systems,
specifically
as
solid
loaded
nanopharmaceuticals,
has
received
recent
years,
although
challenging
formulators
to
convert
them
into
a
successful
form.
The
combination
nanotechnology
field
provided
platform
overcome
challenges
associated
nanomedicine-based
forms.
Therefore,
major
focus
present
manuscript
review
research
developments
that
involved
formulation
utilizing
technology.
Utilization
techniques
nanopharmaceuticals
achieved
transformation
liquid
polymeric
nanocapsules
self-nanoemulsifying
systems
(SNEDDS)
such
tablets
suppositories
easily
customized
doses
per
needs
individual
patient
(personalized
medicine).
Furthermore,
also
highlights
utility
extrusion-based
(Pressure-Assisted
Microsyringe—PAM;
Fused
Deposition
Modeling—FDM)
produce
containing
nanocapsule
SNEDDS
oral
rectal
administration.
critically
analyzes
contemporary
related
impact
process
parameters
performance
Journal of Drug Delivery Science and Technology,
Год журнала:
2024,
Номер
92, С. 105337 - 105337
Опубликована: Янв. 2, 2024
Semi-solid
extrusion
(SSE)
3D
printing
has
great
potential
to
be
integrated
in
a
clinical
setting,
with
the
use
of
pre-filled
and
disposable
pharma-ink
syringes
meeting
regulatory
good
manufacturing
practice
(GMP)
requirements.
Uniformity
mass
testing
is
critical
quality
attribute
carried
out
by
weighing
specific
amount
dosage
units
single
batch
finding
average
evaluate
any
deviations.
However,
this
test
for
small
batches
printed
medicines
may
require
entire
manufactured
batch.
To
overcome
limitation,
an
in-line
analytical
balance
was
implemented
inside
GMP
pharmaceutical
printer,
specialised
software-controlled
system
automated
uniformity
Three
different
dose
(n
=
28)
hydrocortisone
were
subjected
testing.
The
developed
software
capable
registering
weights
all
individual
printlets
accurately
detecting
deviations
within
accepted
limits.
Only
one
printlet
outside
weight
range,
result
first
print
often
being
imperfect
due
semi-solid
nature
pharma-ink.
results
compared
against
external
balance,
no
significant
differences
found.
This
study
integrate
automating
form
which
can
save
time,
labour,
resources,
whilst
improving
control
pharmaceuticals.
Journal of Pharmaceutical Sciences,
Год журнала:
2024,
Номер
113(7), С. 1726 - 1748
Опубликована: Апрель 4, 2024
The
production
of
paediatric
pharmaceutical
forms
represents
a
unique
challenge
within
the
industry.
primary
goal
these
formulations
is
to
ensure
therapeutic
efficacy,
safety,
and
tolerability
in
patients,
who
have
specific
physiological
needs
characteristics.
In
recent
years,
there
has
been
significant
increase
attention
towards
this
area,
driven
by
need
improve
drug
administration
children
optimal
treatments.
Technological
innovation
played
crucial
role
meeting
requirements,
opening
new
frontiers
design
forms.
particular,
three
emerging
technologies
garnered
considerable
interest
scientific
industrial
community:
3D
printing,
prilling/vibration,
microfluidics.
These
offer
advanced
approaches
for
design,
production,
customization
forms,
allowing
more
precise
dosage
modulation,
improved
solubility,
greater
acceptability.
review,
we
delve
into
cutting-edge
their
impact
on
We
analyse
potential,
associated
challenges,
developments,
providing
comprehensive
overview
opportunities
that
innovative
methodologies
sector.
examine
different
generated
using
techniques,
evaluating
advantages
disadvantages.
Pharmaceutics,
Год журнала:
2025,
Номер
17(3), С. 390 - 390
Опубликована: Март 19, 2025
Three-dimensional
printing
technology
is
transforming
pharmaceutical
manufacturing
by
shifting
from
conventional
mass
production
to
additive
manufacturing,
with
a
strong
emphasis
on
personalized
medicine.
The
integration
of
bioinks
and
AI-driven
optimization
further
enhancing
this
innovation,
enabling
drug
precise
dosages,
tailored
drug-release
profiles,
unique
multi-drug
combinations
that
respond
individual
patient
needs.
This
advancement
significantly
impacting
healthcare
accelerating
development,
encouraging
innovative
designs,
treatment
efficacy.
Traditional
follows
one-size-fits-all
approach,
which
often
fails
meet
the
specific
requirements
patients
medical
conditions.
In
contrast,
3D
printing,
coupled
bioink
formulations,
allows
for
on-demand
production,
reducing
dependency
large-scale
storage.
AI-powered
design
process
refine
dosage
forms,
printability,
release
mechanisms,
ensuring
precision
efficiency
in
manufacturing.
These
advancements
have
potential
lower
overall
costs
while
improving
adherence
medication
regimens.
review
explores
potential,
challenges,
environmental
benefits
positioning
it
as
key
driver
next-generation
Drug Delivery and Translational Research,
Год журнала:
2024,
Номер
14(12), С. 3385 - 3403
Опубликована: Янв. 7, 2024
Traditional
approaches
to
solid
rectal
therapies
have
halted
progress,
leading
a
continual
decline
in
the
use
of
conventional
suppositories.
Additive
manufacturing
techniques
been
recently
explored
as
suitable
innovative
tool
for
suppository
fabrication.
However,
little
advancement
has
made
composition
materials
3D-printed
(3DPS)
and
still,
vehicles
are
often
used
construct
fabrication,
hindering
growth
field.
As
novelty,
this
study
unveils
ground-breaking
Laponite-alginate
hydrogel-based
3DPS.
Interestingly,
proposes
novel
approach
loading
drugs
into
3DPS
employing
first
time
post-printing
loading.
Thus,
passive
strategy
molecular
models
is
developed,
demonstrating
versatility
capacity
load
molecules
different
charges
sizes
within
matrix
systems.
This
allows
adapting
wide
range
single
ink,
which
simplifies
speeds
up
technological
development
process
with
physico-chemical
properties.
Additionally,
research,
displacement
three-dimensional
Laponite
matrices
developed
order
enhance
drug
release
through
their
disintegration
capacity,
resulting
significant
improvement
diffusion
hydrogel
rapid
Finally,
our
demonstrates
that
obtained
vivo
behavior,
being
non-obstructive
allowing
normal
motility
rats
intestine.
International Journal of Pharmaceutics,
Год журнала:
2023,
Номер
649, С. 123639 - 123639
Опубликована: Ноя. 30, 2023
Established
medicines
are
often
not
tailored
to
the
needs
of
pediatric
population,
causing
difficulties
with
administration
or
dosing.
Three-dimensional
(3D)
printing
technology
allows
novel
approaches
for
compounding
personalized
medicine,
as
is
exemplified
in
this
study
automated
rectal
preparations
children.
We
investigated
material
requirements
print
prednisolone
phosphate-loaded
suppositories
tunable
dose
and
rapid
drug
release
treatment
inflammatory
bowel
diseases.
Three
formulations
containing
4
%
w/w
sodium
phosphate
(PSP)
different
amounts
hydroxypropyl
cellulose
(HPC)
mannitol
excipients
were
printed
a
fused
deposition
modeling
(FDM)
3D-printer.
Dissolution
studies
showed
that
PSP
rate
was
increased
when
higher
weight
fractions
added
pore
former,
90
within
30
min
48
w/w.
further
infill
densities
dimensions
tune
dose.
Our
findings
demonstrated
3D-printed
doses
ranging
from
6
mg
could
be
compounded
without
notably
affecting
dissolution
kinetics,
ensuring
equivalent
therapeutic
efficacies
doses.